- Home
- MAMA vs GNFT Comparison
MAMA vs GNFT Comparison
Compare MAMA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- GNFT
- Stock Information
- Founded
- MAMA 2010
- GNFT 1999
- Country
- MAMA United States
- GNFT France
- Employees
- MAMA N/A
- GNFT N/A
- Industry
- MAMA Specialty Foods
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAMA Consumer Staples
- GNFT Health Care
- Exchange
- MAMA Nasdaq
- GNFT Nasdaq
- Market Cap
- MAMA 290.7M
- GNFT 190.6M
- IPO Year
- MAMA N/A
- GNFT 2019
- Fundamental
- Price
- MAMA $7.74
- GNFT $3.75
- Analyst Decision
- MAMA Strong Buy
- GNFT Strong Buy
- Analyst Count
- MAMA 4
- GNFT 1
- Target Price
- MAMA $10.50
- GNFT $13.00
- AVG Volume (30 Days)
- MAMA 483.1K
- GNFT 8.9K
- Earning Date
- MAMA 12-16-2024
- GNFT 09-19-2024
- Dividend Yield
- MAMA N/A
- GNFT N/A
- EPS Growth
- MAMA N/A
- GNFT N/A
- EPS
- MAMA 0.08
- GNFT 0.47
- Revenue
- MAMA $116,468,000.00
- GNFT $86,225,222.00
- Revenue This Year
- MAMA $18.91
- GNFT $155.44
- Revenue Next Year
- MAMA $12.69
- GNFT N/A
- P/E Ratio
- MAMA $89.73
- GNFT $7.55
- Revenue Growth
- MAMA 17.20
- GNFT 175.45
- 52 Week Low
- MAMA $4.17
- GNFT $3.31
- 52 Week High
- MAMA $9.98
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- MAMA 33.00
- GNFT 29.68
- Support Level
- MAMA $7.19
- GNFT $3.63
- Resistance Level
- MAMA $7.74
- GNFT $3.94
- Average True Range (ATR)
- MAMA 0.54
- GNFT 0.12
- MACD
- MAMA -0.26
- GNFT 0.03
- Stochastic Oscillator
- MAMA 8.27
- GNFT 0.69
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.